Roxilin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Roxilin

Quick Facts

Property Description
Active ingredient Amoxicillin (INN)
Form Oral forms (Capsules, Tablets, Suspension)
Pharmacological class beta-Lactam antibiotic (Aminopenicillin subclass)
General purpose Elimination of susceptible bacterial pathogens
Origin Semisynthetic

What is Roxilin?

Roxilin: A Semisynthetic beta-Lactam Antibiotic

Roxilin is a prescription-only antimicrobial agent whose core active ingredient is Amoxicillin (Amoxycillin), which fundamentally classifies it as an antibiotic used against bacterial pathogens. The medicine is a semisynthetic derivative belonging to the aminopenicillin subclass, a key group within the broader beta-Lactam antibiotic family. This structure is chemically modified from the original penicillin nucleus to improve patient use. This modification ensures enhanced oral stability and effective absorption from the digestive tract, making it a reliable choice for oral administration.

Composition, Dosage Forms, and General Therapeutic Function

The Roxilin medicinal entity typically operates as a single-active-ingredient product, containing only the therapeutic substance Amoxicillin combined with necessary pharmaceutical excipients. It is distributed in various oral dosage forms, including capsules, tablets, and a powder formulation for an oral suspension, accommodating diverse patient needs, particularly in the pediatric group. The overall purpose of Roxilin is to eliminate pathogenic bacteria susceptible to its action, thereby resolving the underlying infectious process. Roxilin functions as a bactericidal agent, meaning it actively kills susceptible organisms by targeting essential bacterial enzymes required for the final stages of the synthesis of the bacterial cell wall. By interrupting this crucial cell wall construction, the medication causes the bacterial cell structure to fail, leading to the destruction of the pathogen and a reduction in the body's overall bacterial load.

Regulatory References

  1. MedlinePlus

What side effects are possible with Roxilin?

Possible Side Effects and Safety Information

The official safety profile of Roxilin (Amoxicillin) outlines adverse reactions grouped by frequency and the physiological system affected, consistent with regulatory classifications.

Frequency-Classified Adverse Reactions

Adverse reactions classified as common (occurring in up to 1 in 10 patients) primarily involve the gastrointestinal system and skin, most frequently including diarrhea, nausea, and skin rash. Reactions listed as uncommon (up to 1 in 100 patients) include vomiting, pruritus, and urticaria. Rare events, classified as very rare, include serious effects on the blood and lymphatic system, such as reversible leucopenia, and on the liver, such as cholestatic jaundice and hepatitis. Convulsions may also occur, particularly in individuals with impaired renal function.

Serious Adverse Reactions and Constraints

Regulatory documents list several serious adverse reactions, although they are uncommon. These include severe, occasionally fatal, hypersensitivity reactions like anaphylaxis and severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson Syndrome (SJS). Antibiotic-associated colitis (including pseudomembranous colitis) is also a documented concern, and symptoms may occur even after treatment has ended. Roxilin is contraindicated in individuals with a history of a serious allergic reaction to amoxicillin or other beta-lactam antibiotics.

Population and Contextual Safety Notes

Specific safety notes are relevant for certain populations. The medicine should not be administered to patients with mononucleosis due to a high risk of developing a generalized skin rash. For pediatric patients, tooth discoloration has been reported. Furthermore, hepatic events may not become apparent until several weeks after treatment has ceased, illustrating a documented time-related pattern in the safety profile.

Overdose and Emergency Response

Overdose and when to seek help

Documented Overdose Manifestations

Official regulatory documents describe the clinical presentation of a Roxilin (Amoxicillin) overdose as primarily involving pronounced gastrointestinal effects, including nausea, vomiting, and diarrhea. Sustained severe gastrointestinal distress can lead to disturbances of fluid and electrolyte balance. A specific physiological finding documented in overdose cases is crystalluria, which involves the formation of crystals in the urine. This condition may lead to more serious outcomes, including acute renal failure.

Severe Outcomes and Emergency Action

The most serious documented manifestation is the occurrence of convulsions (seizures), which is specifically reported in overdose, particularly in patients with pre-existing impaired renal function. Due to the potential for severe CNS and renal effects, regulators mandate that individuals must seek immediate medical attention or contact emergency services if an overdose is suspected or if severe symptoms, such as convulsions, occur. Hospital monitoring may be required for a period of observation.

Management and Regulatory Constraints

Management in overdose is defined as symptomatic and supportive treatment. The official documentation states that no specific antidote is known for Roxilin overdose. Supportive measures include maintaining adequate fluid intake to promote urine output and help reduce the risk of crystalluria. Hemodialysis is listed as a specific intervention that can be used to remove the antibiotic from the body.

Therapeutic Uses of Roxilin

What Roxilin Treats: Main Uses and Benefits

Roxilin (Amoxicillin) is generally used in clinical settings to help address a wide array of bacterial infections across several body systems. This therapeutic application is relevant for managing conditions that cause noticeable physiological strain and heightened patient distress.

It is commonly applied across therapeutic domains involving acute infections of the upper and lower respiratory tracts, the middle ear, and the genitourinary system. This includes managing conditions like acute otitis media, strep throat (pharyngitis), tonsillitis, and uncomplicated urinary tract infections (UTIs), as well as addressing skin and soft tissue infections and dental abscesses. The medication is helpful when groups of symptoms, such as intense localized pain and systemic fever, appear suddenly. The overall therapeutic goal is commonly used to help with acute or disruptive episodes where symptoms may intensify temporarily.

Quick Fact: Relief for Acute Discomfort

Area of Use Symptom Management Focus
Respiratory/ENT Helps address intense ear pain, sore throat, and fever associated with acute infections.
Localized Tissue Relevant for easing discomfort and swelling related to dental abscesses and skin infections.
Specialized Context Applied for prophylactic coverage in high-risk patients to help address the risk of certain challenging infections (e.g., infectious endocarditis).

Eligibility and Restrictions for Use

Who Can and Cannot Use Roxilin?

Roxilin (Amoxicillin) is subject to official eligibility rules defined by government regulatory agencies. The restrictions primarily address immune history, specific concurrent medical conditions, and physiological state.

Eligibility Status Population Restriction
Contraindicated Patients with a serious hypersensitivity reaction history (e.g., anaphylaxis) to Roxilin, other penicillins, or cephalosporins.
Non-Recommended Use Patients with infectious mononucleosis (due to the documented high risk of developing a non-allergic skin rash).

The medicine is established for use in adults and pediatric patients aged over three months. Use in neonates and infants 12 weeks or younger is restricted due to incompletely developed renal function, which can delay drug elimination. Caution is advised for older adults, who are more likely to have age-related decreases in renal function.

Patients with severe renal impairment (GFR less than 30 mL/ min) must receive a restricted and modified administration schedule; specific high-strength products are prohibited in this group. For pregnancy, use is permitted only if clearly needed. Lactation requires caution, as the drug is excreted in human milk.

What should I know about interactions with other medicines?

Roxilin Interactions with Other Medicines and Products

Official regulatory information documents interactions between Roxilin (Amoxicillin) and several other medicines, primarily concerning changes in drug concentration or alterations to physiological processes like blood clotting. No combinations are formally classified as a contraindication in regulatory documents.


Documented Interaction Patterns

Interacting Substance/Class Official Interaction Description
Probenecid (Gout) Decreases the renal tubular secretion of Roxilin, which may result in increased blood levels of the antibiotic.
Oral Anticoagulants May increase the prolongation of prothrombin time (INR) and the risk of bleeding.
Allopurinol (Gout) Coadministration is associated with an increased risk of rash.
Oral Contraceptives May reduce the efficacy of combined oral estrogen/progesterone contraceptives.

Specific Interaction Notes

  • Methotrexate: High doses of Roxilin have been associated with increased methotrexate toxicity due to reduced elimination.
  • Bacteriostatic Agents: Antibiotics such as Chloramphenicol, macrolides, and tetracyclines may interfere with the bactericidal effects of Roxilin.
  • Population Considerations: The interaction with Oral Anticoagulants requires more frequent monitoring in the elderly or patients with renal or hepatic impairment, as stated in regulatory labels.

Mechanism of Action

Mechanism of Action: How Roxilin Works

The action of Roxilin (Amoxicillin) is purely bactericidal, operating by interfering with fundamental processes required for bacterial cell wall integrity. The mechanism targets specific biological structures unique to the pathogen, leading to its destruction.


Irreversible Inhibition of Cell Wall Synthesis

Roxilin exerts its primary effect by acting as an irreversible inhibitor of bacterial Penicillin-Binding Proteins (PBPs), a family of enzymes essential for synthesizing the bacterial cell wall. The drug covalently binds to these enzymes, permanently halting the final stage of peptidoglycan cross-linking. This molecular blockade modifies early structural steps that shape the subsequent systemic outcome.


Catastrophic Cellular Failure

The permanent inhibition of PBPs causes an immediate failure in the bacteria's structural integrity, as the rigid cell wall cannot be properly completed or maintained. This structural defect renders the bacterial cell vulnerable to internal osmotic pressure, leading to the rapid activation of internal autolytic enzymes and ultimately cell lysis and death. This active bactericidal cascade is the mechanism that results in the destruction of the bacterial population.

Dosage and Administration Information

The administration of Roxilin (Amoxicillin) is standardized across its dosage forms, which include capsules, tablets, and powder for oral suspension. The medicine is for oral use.

Standardized Dosing and Frequency

Dosing regimens are typically structured as a fixed interval, most commonly either every eight hours (q8h) or every twelve hours (q12h). Adult doses commonly range from 250 mg to 875 mg per dose, depending on the severity of the regimen. For pediatric patients weighing less than 40 kg, the dose is calculated based on body weight, with standard recommendations generally falling in the range of 20 to 45 mg/kg/day in divided doses. Infants less than or equal to 3 months require a specific maximum dose, divided every 12 hours.

Administration Conditions and Duration

The treatment course generally ranges from 5 to 14 days, with a minimum duration of 10 days maintained for certain infections, such as those caused by Streptococcus pyogenes. Standard capsule and suspension forms can be taken without regard to meals. However, formulations like the 875 mg tablet or extended-release versions are designated to be taken at the start of a light meal to optimize administration. The oral suspension requires reconstitution with a specific amount of water and is measured using a calibrated device, not a household spoon.

Population Adjustments

Patients with severe renal impairment (Glomerular Filtration Rate, GFR, < 30 mL/min) require an adjustment to the dose interval and maximum daily amount to prevent drug accumulation. If a dose is missed, it is taken as soon as remembered, but is skipped if it is near the time for the next scheduled dose, in accordance with the principle of not taking a double dose.

Recent Clinical Evidence

Overview of Studies for Roxilin

The clinical foundation for Roxilin primarily includes evidence from randomized controlled trials (RCTs) and systematic reviews. These studies have been used in research exploring how symptoms change over time across various acute bacterial conditions, contributing to the broader evidence landscape for the aminopenicillin class of antibiotics.

Evidence for Use in Acute Otitis Media (AOM)

The most extensive research focuses on the treatment of AOM in children. RCTs comparing Roxilin to placebo or observation monitored patient-reported outcomes, such as ear pain and fever, and clinical resolution at 10 to 14 days. Studies observed that the measured frequency of reported fever and pain was lower in the Roxilin group compared to the placebo groups during the initial 48 hours. However, follow-up durations were limited for long-term complications; studies generally found no significant differences between Roxilin and control groups when monitoring recurrence rates at 1 or 3 months.

Evidence for Use in Streptococcal Pharyngitis

Roxilin was evaluated in comparative studies, often against Penicillin V, focusing on bacteriological eradication (elimination of the pathogen). Studies reported that the measured rate of achieving bacterial eradication with Roxilin was observed to be similar to the rates reported for Penicillin V. The focus of this research is the acute-phase eradication of the pathogen.

What is Still Uncertain

Evidence quality varies across indications. The evidence for certain prophylactic uses is rated as Low due to the absence of high-quality RCTs needed to provide definitive conclusions on clinical effectiveness. Furthermore, the increasing challenge of antibiotic resistance means that its utility for conditions like uncomplicated urinary tract infections is sometimes affected by local resistance patterns, and evidence for these uses is characterized as limited and heterogeneous. Comparative evidence is lacking against certain recently developed antibiotics.

Key Studies & References Otitis media (acute): antimicrobial prescribing (NICE Guideline NG91)

Frequently Asked Questions (FAQ)

Common questions about Roxilin (FAQ)


Q: Is Roxilin the same kind of medicine as other drugs that treat similar issues?

Official regulatory documents describe Roxilin as belonging to the penicillin family of antibacterial drugs. It is classified as an aminopenicillin, which is a key subclass within the broader group of beta-lactam antibiotics. This means it has a specific mechanism of action against certain bacterial pathogens, similar to other medicines in the penicillin family.

Q: What health problems is Roxilin specifically approved to treat?

The medication is approved by regulatory bodies for treating infections caused by susceptible bacteria. This includes infections of the ear, nose, throat, and the genitourinary tract. It is also indicated for certain infections of the skin structure and the lower respiratory tract, as well as being used in combination therapy for Helicobacter pylori infection.

Q: How long does it take for Roxilin to leave the body?

Pharmacokinetic data from regulatory information indicates the half-life of Roxilin in adults with normal kidney function is approximately 61.3 minutes. The majority of the drug is excreted, primarily unchanged, in the urine within 6 to 8 hours after administration.

Q: Is it common to feel tired while taking Roxilin?

Fatigue or generalized tiredness is not typically listed among the common side effects detailed in clinical trial data. However, official information does note that other nervous system effects, such as headache or dizziness, are reported in post-marketing surveillance.

Q: Can Roxilin affect my sleep schedule?

Nervous system adverse reactions reported during post-marketing surveillance include sleeplessness, trouble with sleeping, and agitation.

Q: Are there any foods or drinks that absolutely need to be avoided while using Roxilin?

Official product information states that Roxilin is generally stable in the digestive system and is rapidly absorbed after being taken orally. Standard forms of the medication may be taken without regard to meals.

Q: Is Roxilin safe to take if I have liver problems?

Adverse reactions affecting the liver, such as hepatitis and cholestatic jaundice, are listed in official post-marketing reports. Official guidance emphasizes the importance of informing your healthcare provider about any history of kidney or liver conditions.

Q: Is there a generic version of Roxilin available?

Roxilin is the brand name for the active ingredient Amoxicillin. Amoxicillin is a common drug that is widely available as a generic medication.

Q: Does Roxilin interact with common pain relievers like ibuprofen or acetaminophen?

The official regulatory label does not list a specific direct interaction with common pain relievers such as ibuprofen or acetaminophen. All medications and side effects should be reviewed with your healthcare provider.

Q: Can I take vitamins or supplements while I am taking Roxilin?

Official guidelines describe the importance of discussing all prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products with a healthcare provider. This is essential for assessing any potential for interaction.

Q: Can Roxilin cause changes in mood or behavior?

Post-marketing reports of adverse reactions include changes in behavior, agitation, and confusion. These are listed among the less frequent effects, according to regulatory data.

Q: What is the risk of dependence or addiction with Roxilin?

Roxilin (Amoxicillin) is not classified as a controlled substance by regulatory bodies, such as the U.S. Drug Enforcement Administration. Therefore, it has no known risk of dependence or addiction.

Q: Do official documents mention any effects of Roxilin on blood sugar levels?

Regulatory warnings mention that high urine concentrations of Roxilin can cause false-positive readings when testing for glucose in urine using certain copper reduction tests. This interference is with the test itself and does not indicate an actual effect on a person's blood sugar levels.

Q: Can Roxilin cause sun sensitivity or skin issues?

Official documents describe common skin reactions such as rash and urticaria (hives), and they also list severe skin reactions. However, regulatory sources do not specifically list sun sensitivity, or photosensitivity, as a known side effect.

Q: Has Roxilin been approved by major regulatory bodies like the FDA or EMA?

Yes, the medication is approved and regulated by major international governmental authorities for the specific medical uses outlined in the official product information.

Q: Does Roxilin interact with alcohol, according to official warnings?

The official prescribing information does not list alcohol as a specific drug interaction. Official documents recommend that patients discuss all medication and substance use with their healthcare provider.

Q: Can people with a history of heart problems use Roxilin?

Heart problems are not listed in official documents as a specific contraindication for the use of Roxilin. The main restriction concerns individuals with a history of serious allergic reactions to penicillins. Official guidance emphasizes the importance of discussing all pre-existing medical conditions with the healthcare provider.

Q: Are there any known interactions between Roxilin and common cold/flu medications?

The regulatory documents do not list a direct interaction between Roxilin and general cold/flu medications. Official guidance describes the importance of discussing the ingredients of all non-prescription medicines with a healthcare provider.

Q: Is it necessary to have routine blood tests while taking Roxilin?

For some patients, a healthcare provider may order certain laboratory tests to monitor the body’s response to Roxilin. This is especially true during prolonged use or if there are pre-existing kidney or liver conditions.

Q: Can Roxilin be crushed or broken if swallowing is difficult?

Official administration instructions state that extended-release tablets are formulated to be swallowed whole and are not to be crushed or chewed. Specific directions for standard tablets or capsules should be reviewed, and an oral suspension (liquid) form is also available.

Q: Do research trials show different results for different age groups using Roxilin?

Clinical evidence supports different dosing requirements based on age and weight. Dosage recommendations are distinct for adults, pediatric patients over three months of age, and infants, which indicates that clinical data informs these varied administration schedules.

Q: Does Roxilin have any potential interaction with natural or herbal products?

Regulatory guidance on patient counseling emphasizes the importance of discussing all herbal products and supplements with a healthcare provider. This allows them to assess any potential for interaction.

Q: Why are there different strengths or forms of Roxilin available?

Regulatory documents list different strengths and forms, such as capsules, tablets, and oral suspension. This variety is intended to allow for flexible dosing that is appropriate for the severity of the infection and tailored to the patient’s age or body weight.

Q: Does Roxilin interfere with driving or operating heavy machinery?

Official information notes that nervous system adverse reactions, such as dizziness, confusion, or convulsions, have been reported. These types of effects may potentially interfere with a person’s ability to drive or operate heavy machinery.

Q: Is Roxilin a controlled substance in [Country X]?

Roxilin (Amoxicillin) is not classified as a controlled substance under the U.S. Controlled Substances Act. This regulatory status indicates it does not have the potential for abuse or dependence.

Q: What does the term 'contraindication' mean regarding Roxilin?

In regulatory terms, a contraindication is a specific medical condition or factor that absolutely forbids a certain treatment because it would cause patient harm. For Roxilin, the primary contraindication is a serious allergic reaction history to any penicillin.

Q: Are there any long-term effects of taking Roxilin that official documents mention?

Official documents note that serious adverse effects can manifest even after the treatment course has been completed. For example, Clostridioides difficile-associated diarrhea (CDAD) has been reported in patients up to two months or more after finishing the antibacterial treatment.

Q: Can Roxilin affect fertility in men or women?

Official sources provide no evidence to suggest that the use of Roxilin affects fertility in either men or women.

Q: Is it safe to get vaccines while taking Roxilin?

Antibiotics are generally not known to interfere with the content or effectiveness of vaccines. Regulatory guidance indicates that if a patient is experiencing moderate or severe illness, vaccination may be temporarily postponed until recovery.

Q: Can children 2 years old use it?

Official dosage recommendations are established for pediatric patients older than three months of age. Dosage for this age group is determined based on the patient’s body weight.

Q: What kind of monitoring is typically advised while on Roxilin?

Official guidance describes that keeping all scheduled appointments with the healthcare provider and the laboratory is a typical component of patient care. Lab tests may be ordered to check the body’s response, particularly during prolonged duration of use.

How should Roxilin be stored and disposed of?

The official storage and disposal requirements for Roxilin (Amoxicillin) are specifically mandated by regulatory documents to preserve the antibiotic's potency.

Official Storage Conditions

Dosage Form Required Storage Conditions
Capsules/Tablets/Dry Powder Store at room temperature (typically not exceeding 30 C). Keep in a closed container, away from direct light and moisture.
Reconstituted Suspension Refrigeration (2 C to 8 C) is required or preferable, as dictated by the label. Do not freeze the liquid suspension.

Stability and Disposal

The reconstituted suspension must be discarded after 14 days if stored in the refrigerator, or within 7 days if stored at room temperature, as stability is time-limited. All forms of Roxilin must be kept out of the reach of children. Unused or expired medicine must be disposed of in accordance with local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Roxilin found in:

A-Z Index: